We are live on ! Find out more
AUPH icon

Aurinia Pharmaceuticals
AUPH

199 hedge funds and large institutions have $510M invested in Aurinia Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 54 increasing their positions, 44 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 26

51% more call options, than puts

Call options by funds: $34.3M | Put options by funds: $22.7M

23% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 44

8% more funds holding

Funds holding: 184 → 199 (+15)

5.32% more ownership

Funds ownership: 30.48% → 35.8% (+5.3%)

4% less capital invested

Capital invested by funds: $533M → $510M (-$22.5M)

Holders
199
Holders Change
+15
Holders Change %
+8.15%
% of All Funds
3.35%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
43
Increased
54
Reduced
44
Closed
26
Calls
$34.3M
Puts
$22.7M
Net Calls
+$11.5M
Net Calls Change
-$39M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$66.9M
2
State Street
State Street
Massachusetts
+$20.8M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$11.8M
4
Northern Trust
Northern Trust
Illinois
+$10.3M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$7.14M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$17.5M
2
Renaissance Technologies
Renaissance Technologies
New York
-$12.2M
3
SG Americas Securities
SG Americas Securities
New York
-$8.71M
4
Millennium Management
Millennium Management
New York
-$8.08M
5
IBT
International Biotechnology Trust
United Kingdom
-$4.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
NFG
26
Norris Financial Group
South Carolina
$4.14M +$252K +22,546 +6%
GF
27
Gabelli Funds
New York
$3.92M – – –
Wells Fargo
28
Wells Fargo
California
$3.81M -$1.14M -102,013 -21%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$3.73M +$4.15M +371,497 New
HWAM
30
Hennion & Walsh Asset Management
New Jersey
$3M +$363K +32,450 +12%
Charles Schwab
31
Charles Schwab
California
$2.98M +$3.31M +296,201 New
Swiss National Bank
32
Swiss National Bank
Switzerland
$2.62M – – –
ASN
33
Advisory Services Network
Georgia
$2.54M +$10.6K +950 +0.4%
HSBC Holdings
34
HSBC Holdings
United Kingdom
$2.32M -$2.8M -250,056 -52%
HP
35
HealthInvest Partners
Sweden
$2.31M +$2.57M +230,000 New
Parallax Volatility Advisers
36
Parallax Volatility Advisers
California
$2.02M -$21.5K -1,927 -1%
ECM
37
ExodusPoint Capital Management
New York
$1.81M +$292K +26,148 +17%
GGHC
38
Gilder Gagnon Howe & Co
New York
$1.81M -$201K -17,969 -9%
LSA
39
Leonteq Securities AG
Switzerland
$1.78M -$53.1K -4,751 -3%
Hudson Bay Capital Management
40
Hudson Bay Capital Management
Connecticut
$1.77M +$168K +15,000 +9%
WP
41
Woodline Partners
California
$1.7M +$1.89M +169,209 New
CF
42
Cantor Fitzgerald
New York
$1.68M +$1.87M +167,223 New
TCM
43
Tekla Capital Management
Massachusetts
$1.63M – – –
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$1.53M +$1.7M +151,876 New
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$1.52M +$633K +56,648 +60%
UBS Group
46
UBS Group
Switzerland
$1.51M -$286K -25,549 -15%
DnB Asset Management
47
DnB Asset Management
Norway
$1.47M -$1.09M -97,587 -40%
Capital Fund Management (CFM)
48
Capital Fund Management (CFM)
France
$1.42M -$6.77K -606 -0.4%
AllianceBernstein
49
AllianceBernstein
Tennessee
$1.36M +$386K +34,500 +34%
JF
50
Jump Financial
Illinois
$1.34M +$127K +11,353 +9%
1
2
3 4 5

AUPH Hedge Fund Activity: Q2 2022 in Review

199 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Aurinia Pharmaceuticals (AUPH) for Q2 2022, worth a combined $510M — down 4.2% from $533M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new AUPH positions and 26 closed out — a net gain of 17 holders — while 54 added to existing stakes and 44 trimmed.

The largest buyer was BlackRock, adding an estimated $66.9M. The largest seller was Fidelity Investments, cutting an estimated $17.5M.

  • 199 institutional investors held Aurinia Pharmaceuticals (AUPH) as of Q2 2022, up from 184 in Q1 2022.
  • Funds reported $510M of Aurinia Pharmaceuticals stock for Q2 2022, down 4.2% quarter-over-quarter.
  • 43 funds opened new Aurinia Pharmaceuticals positions in Q2 2022 and 26 closed out, a net change of +17 holders.
  • The largest Aurinia Pharmaceuticals buyer in Q2 2022 was BlackRock, an estimated $66.9M added.
  • The largest Aurinia Pharmaceuticals seller in Q2 2022 was Fidelity Investments, an estimated $17.5M sold.

Based on aggregated 13F filings for Q2 2022.